Ceretype Neuromedicine
Cambridge, MA
Ceretype has pioneered the integration of fMRI into therapeutic applications in neuropsychiatry. Our uniquely scalable platform makes targeted biomarkers accessible, delivering actionable insights for our pharma/biotech partners. Our decades of expertise across neuromedicine, brain imaging, and industry processes enables innovations that will ultimately transform patient care.
ceretype.comCompany Details
Founded
- 2020
Employees
- Between 5 - 20 employees
Raised
- $4,350,000
Headquarters Location
- Cambridge, MA
Public
- No
Acquired
- No
CEO
- Emily Stern
Founders
- David SilbersweigEmily SternHong Pan
Company Collections
These are collections Ceretype Neuromedicine is a part of. Click on the collection name to view similar companies.